# US 2022/0394987 A1 · Methods and systems for generating a sterilized human milk product

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2022/0394987 A1
- Document ID: US20220394987A1
- Status: Published application
- Kind: A1
- Application number: 17/891,002
- Filed: 2022-08-18
- Published: 2022-12-15
- Earliest claimed: 2016-10-04
- Applicants: LactaLogics, Inc.
- Inventors: Glenn W. Snow; Rachelle J. Snow
- Web page: https://patentgrep.com/patent/US20220394987A1

## CPC

- A23C 9/206: {Colostrum; Human milk}
- A23B 2/40: by heating loose unpacked materials
- A23B 11/133: and progressively transported through the apparatus
- A23L 33/19: Dairy proteins
- A23L 33/40: {Complete food formulations for specific consumer groups or specific purposes, e.g. infant formula}
- A23C 2210/256: Removal or separation of bacteria, or a fraction containing bacteria, by centrifugation; Bactofugation
- A23V 2002/00: Food compositions, function of food ingredients or processes for food or foodstuffs
- A61K 35/20: Milk; Whey; Colostrum
- A61K 38/00: Medicinal preparations containing peptides (peptides containing beta-lactam rings A61K31/00; cyclic dipeptides not having in their molecule any other peptide link than those which form their ring, e.g. piperazine-2,5-diones, A61K31/00; ergot alkaloids of the cyclic peptide type A61K31/48; containing macromolecular compounds having statistically distributed amino acid units A61K31/74; medicinal preparations containing antigens or antibodies A61K39/00; medicinal preparations characterised by the non-active ingredients, e.g. peptides as drug carriers, A61K47/00)
- C07K 2317/12: isolated from milk
- A23C: DAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; PREPARATION THEREOF (preservation thereof A23B11/00)
- A23B: PRESERVATION OF FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES; CHEMICAL RIPENING OF FRUIT OR VEGETABLES
- A23L: FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF (preservation thereof A23B)
- A23V: INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A61K: PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms A61J3/00; chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles A61L; soap compositions C11D)
- C07K: PEPTIDES (peptides in foodstuffs A23; obtaining protein compositions for foodstuffs, working-up proteins for foodstuffs A23J; preparations for medicinal purposes A61K; peptides containing beta-lactam rings C07D; cyclic dipeptides not having in their molecule any other peptide link than those which form their ring, e.g. piperazine-2,5-diones, C07D; ergot alkaloids of the cyclic peptide type C07D519/02; macromolecular compounds having statistically distributed amino acid units in their molecules, i.e. when the preparation does not provide for a specific; but for a random sequence of the amino acid units, homopolyamides and block copolyamides derived from amino acids C08G69/00; macromolecular products derived from proteins C08H1/00; preparation of glue or gelatine C09H; single cell proteins, enzymes C12N; genetic engineering processes for obtaining peptides C12N15/00; compositions for measuring or testing processes involving enzymes C12Q; investigation or analysis of biological material G01N33/00)

## Abstract

Systems and methods for generating a sterilized human milk product from raw human milk, and sterilized human milk product compositions obtained thereby, are provided. The method includes sterilizing the milk using a countercurrent heating process. The temperature of the milk is raised to a target temperature for a duration of time that is refined to provide a sterilized human milk product with low overall bioburden while also maintaining nutritional quality. As such, the sterilized milk product is suitable for ingestion by premature infants.

## Claims

### Claim at position 1

1-30. (canceled)

### Claim 31

A sterilized human milk product, comprising:
human lactoferrin, at a concentration that is 81% or greater of the average concentration of lactoferrin in raw human milk; and
human immunoglobulin A (IgA), at a concentration that is 73% or greater of the average concentration of IgA in raw human milk,
wherein the sterilized human milk product has a bacterial aerobic plate count of less than 10 CFUs per gram of the sterilized human milk product.

### Claim 32 (depends on 32)

The sterilized human milk product of claim 32, wherein the sterilized human milk product comprises less than 10% of pathogens of the average amount of pathogens in raw human milk.

### Claim 33 (depends on 32)

The sterilized human milk product of claim 32, wherein the pathogens are selected from: Bacillus cereus spores and Clostridium botulinum spores.

### Claim 34 (depends on 33)

The sterilized human milk product of claim 33, wherein the concentration of Bacillus cereus spores is at least 100-fold lower than the average concentration of Bacillus cereus in raw human milk.

### Claim 35 (depends on 33)

The sterilized human milk product of claim 33, wherein the concentration of Bacillus cereus spores is at least 500-log lower than the average concentration of Bacillus cereus in raw human milk.

### Claim 36 (depends on 33)

The sterilized human milk product of claim 33, wherein the concentration of Clostridium botulinum spores is at least 100-fold lower than the average concentration of Clostridium botulinum in raw human milk.

### Claim 37 (depends on 36)

The sterilized human milk product of claim 36, wherein the concentration of Clostridium botulinum spores is at least 12-log lower than the average concentration of Clostridium botulinum in raw human milk.

### Claim 38 (depends on 33)

The sterilized human milk product of claim 33, wherein the sterilized human milk product has yeast and mold counts of fewer than 10 CFUs per gram of the sterilized human milk product.

### Claim 39 (depends on 33)

The sterilized human milk product of claim 33, wherein the sterilized human milk product further comprises human immunoglobulin G (IgG) at a concentration that is 77% or greater of the average concentration of IgG in raw human milk.

### Claim 40 (depends on 39)

The sterilized human milk product of claim 39, wherein the sterilized human milk product further comprises 2′fucosyllactose at a concentration of between 0.72 grams per liter and 4.3 grams per liter of the sterilized human milk product.

### Claim 41 (depends on 40)

The sterilized human milk product of claim 40, wherein the sterilized human milk product further comprises human osteopontin at a concentration that is 87% or greater of the average concentration of osteopontin in raw human milk.

### Claim 42 (depends on 41)

The sterilized human milk product of claim 41, further comprising human immunoglobulin M (IgM) at a concentration that is 77% or greater of the average concentration of IgM in raw human milk.

### Claim 43 (depends on 31)

The sterilized human milk product of claim 31, wherein the sterilized milk product has a protein digestibility corrected amino acid score (PDCAAS) of at least about 72.4% w/w.

### Claim 44 (depends on 31)

The sterilized human milk product of claim 31, wherein the sterilized human milk product has a nitrogen utilization (NNU) protein concentration, wherein at least 95% of a weight of amino acids in the NNU composition are free amino acids.

### Claim 45 (depends on 44)

The sterilized human milk product of claim 44, wherein the free amino acids are not bonded by a peptide bond to other amino acids.

### Claim 46 (depends on 14)

The sterilized human milk product of claim 14, wherein the amino acids are in form of L-isomer.

### Claim 47 (depends on 44)

The sterilized human milk product of claim 44, wherein the amino acids are selected from: isoleucine, leucine, lysine, methionine, phenylalanine, threonine, tryptophan, valine and histidine.

### Claim 48

A sterilized human milk product, wherein the product has, per 100 milliliters:
(a) 1.0 to 2.1 grams of protein,
(b) 0.081 grams to 1.328 grams of human lactoferrin;
(c) at least 0.268 grams of human lactalbumin;
(d) 63 to 67 calories,
(e) 30 to 34 calories from fat,
(f) 1.2 to 1.8 grams of saturated fat,
(g) 10 to 16 mg of cholesterol,
(h) 10 to 20 mg of sodium,
(i) 4 to 10 grams of total carbohydrate,
(j) 4 to 7 grams of sugars,
(k) 160 to 200 International Units of vitamin A, and
(l) 27 to 35 mg of calcium,
wherein the sterilized human milk product has:
a bacterial aerobic plate count of less than 10 CFUs per gram of the sterilized human milk product;
a concentration of Bacillus cereus spores that is at least 10-fold lower than the average concentration of Bacillus cereus in raw human milk; and
a concentration of Clostridium botulinum spores that is at least 100-fold lower than the average concentration of Clostridium botulinum in raw human milk.
